Tirzepatide vs. Semaglutide: How They Differ
Tirzepatide and semaglutide are the two names that come up most when people ask about medical weight loss. Both are once-weekly injections, both can lead to meaningful weight loss, and both have helped bring GLP-1 medications into everyday conversation. They are not the same medication, though. Here is a plain-language look at how they differ and what to discuss with your provider.
How Semaglutide Works
Semaglutide mimics GLP-1, a natural hormone your gut releases after you eat. GLP-1 signals fullness to the brain, slows how quickly the stomach empties and helps regulate blood sugar. The result for many people is smaller appetite, fewer cravings and less snacking between meals. Brand-name versions include Wegovy for weight management and Ozempic for type 2 diabetes.
How Tirzepatide Works
Tirzepatide acts on GLP-1 receptors too, but it also targets a second hormone called GIP. Working on both pathways is why it is often called a dual agonist. Researchers believe the added GIP activity contributes to its effect on appetite and how the body handles sugar and fat. Brand-name versions include Zepbound for weight management and Mounjaro for type 2 diabetes.
What the Head-to-Head Research Shows
In 2025, the SURMOUNT-5 trial published in the New England Journal of Medicine compared the two directly in adults with obesity who did not have type 2 diabetes. Over 72 weeks, participants taking tirzepatide lost an average of about 20 percent of their body weight, compared with about 14 percent for those taking semaglutide. Both groups also made lifestyle changes alongside their medication.
Averages do not predict any one person's results. Some people do very well on semaglutide, some respond better to tirzepatide, and tolerance to side effects plays a big role in which one works long term.
Side Effects to Know About
Both medications share a similar side effect profile, and most issues are digestive:
Nausea, especially after starting or increasing a dose
Constipation or diarrhea
Reduced appetite that can make it easy to under-eat protein
Fatigue in the first few weeks
Starting at a low dose and increasing slowly helps many people adjust. Neither medication is right for people with a personal or family history of medullary thyroid cancer or MEN 2 syndrome, and your provider will review your history, including pancreas and gallbladder health, before prescribing.
How to Choose
There is no single best option for everyone. The right choice depends on your goals, health history, how you tolerate the medication and your budget. Questions worth asking your provider:
Based on my labs and history, which option fits me better?
What starting dose do you recommend, and how will we adjust it?
How should I manage side effects if they show up?
What should I eat and how should I train to protect muscle?
About Compounded Options
Brand-name semaglutide and tirzepatide are FDA approved. Compounded versions, like those prescribed through CommonwealthMD and filled by regulated U.S. 503A pharmacies, are not FDA approved. Your provider will explain the differences and help you decide what makes sense for you.
Talk to a Provider in Pittsburgh
Not sure which is right for you? Start with an at-home lab kit, then book a consultation with a licensed provider who can walk you through both options. Browse weight loss options and consultations in our shop.
This article is for general education and is not medical advice. Talk with a licensed provider before starting any treatment. Results vary.
